10x Genomics (TXG) Asset Utilization Ratio (2019 - 2026)

10x Genomics has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.62 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.62, down 9.43% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.62 (down 9.43% YoY), and the FY2025 annual result was 0.66, up 1.15% from the prior year.
• Asset Utilization Ratio came in at 0.62 for Q1 2026 at 10x Genomics, roughly flat from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q1 2025 to a low of 0.49 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.62 (2025), against an average of 0.6.
• Across the five-year window, Asset Utilization Ratio surged 39.72% in 2022 and decreased 9.43% in 2026, its largest moves.
• 10x Genomics' Asset Utilization Ratio stood at 0.51 in 2022, then rose by 26.79% to 0.65 in 2023, then grew by 1.76% to 0.66 in 2024, then fell by 5.56% to 0.62 in 2025, then decreased by 0.07% to 0.62 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.62 (Q1 2026), 0.62 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.